Sudden Infant Death Syndrome

Description

Sudden infant death syndrome (SIDS) is a diagnosis of exclusion which should be made only after a thorough autopsy without identification of a specific cause of death (Mage and Donner, 2004).Weese-Mayer et al. (2007) provided a detailed review of genetic factors that have been implicated in SIDS. The authors concluded that SIDS represents more than 1 entity and has a heterogeneous etiology most likely involving several different genetically controlled metabolic pathways.

Clinical Features

Top most frequent phenotypes and symptoms related to Sudden Infant Death Syndrome

  • Fever
  • Respiratory distress
  • Abnormal heart morphology
  • Pneumonia
  • Acidosis
  • Hypoglycemia
  • Apnea
  • Small for gestational age
  • Hepatic steatosis
  • Coma

And another 11 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Sudden Infant Death Syndrome Is also known as sids.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Sudden Infant Death Syndrome Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE) Evaluation (TYMP, RRM2B, MELAS).

By Athena Diagnostics Inc (United States).

RRM2B, TYMP, MT-TL1
Specificity
34 %
Genes
12 %
Progressive External Ophthalmoplegia Evaluation (POLG, TWINKLE, ANT1, OPA1, MELAS).

By Athena Diagnostics Inc (United States).

SLC25A4, TWNK, MT-TL1, OPA1, POLG
Specificity
20 %
Genes
12 %
Common Mitochondrial Disorders Evaluation (POLG, MELAS, MERRF, NARP).

By Athena Diagnostics Inc (United States).

MT-TK, MT-TL1, POLG
Specificity
34 %
Genes
12 %
MELAS mtDNA Evaluation.

By Athena Diagnostics Inc (United States).

MT-TL1
Specificity
100 %
Genes
12 %
Juvenile myopathy, encephalopathy, lactic acidosis AND stroke.

By Center for Human Genetics, Inc (United States).

MT-TL1
Specificity
100 %
Genes
12 %
OtoSCOPE.

By Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics (United States).

ROR1, SIX1, SIX5, SLC22A4, SNAI2, SMPX, SOX10, TBX1, TWNK, TCOF1, TECTA, TIMM8A, TJP2, TMPRSS3, USH1C, USH2A, CLRN1, TSPEAR, WFS1, ESPN , (...)

View the complete list with 130 more genes
Specificity
2 %
Genes
23 %
Comprehensive Mitochondrial Metabolic Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).

BCS1L, SCO1, SCO2, SDHB, SDHC, SDHD, SLC22A5, SLC25A13, SLC25A15, SLC25A3, SLC25A4, BTD, SUCLA2, SUCLG1, SURF1, TAZ, TWNK, TCN2, TFAM, TIMM8A , (...)

View the complete list with 173 more genes
Specificity
2 %
Genes
23 %
Mitochondrial Genome Sequence.

By Molecular Genetics Laboratory Centro de Investigaciones Endocrinologicas "Dr. Cesar Bergada" (Argentina).

MT-CO1, MT-CO2, MT-CO3, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-RNR1, MT-RNR2, MT-TA, MT-TC, MT-TD, MT-TE, MT-TF, MT-TG, MT-TH , (...)

View the complete list with 15 more genes
Specificity
6 %
Genes
23 %

You can get up to 536 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM MESH Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H; LGMD2H CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 1, SUSCEPTIBILITY TO; CAKUT1 AUTISM, SUSCEPTIBILITY TO, 18; AUTS18 ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1 MUSCLE-EYE-BRAIN DISEASE